David Jayne1. Show Affiliations » 1. Vasculitis & Lupus Clinic, Addenbrooke's Hospital, Box 118, Cambridge, United Kingdom. dj106@cam.ac.uk
Abstract
Entities: Chemical Disease
Mesh： See more » Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapyAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/immunologyAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/mortalityAntibodies, Antineutrophil Cytoplasmic/bloodAntibodies, Monoclonal, Murine-Derived/adverse effectsAntibodies, Monoclonal, Murine-Derived/therapeutic useAzathioprine/adverse effectsAzathioprine/therapeutic useB-Lymphocytes/drug effectsCyclophosphamide/therapeutic useDisease-Free SurvivalDrug Therapy, CombinationHumansImmunologic Factors/adverse effectsImmunologic Factors/therapeutic useImmunosuppressive Agents/adverse effectsImmunosuppressive Agents/therapeutic useLong-Term CarePrednisolone/adverse effectsPrednisolone/therapeutic useRandomized Controlled Trials as TopicRituximabSecondary PreventionTreatment OutcomeUnited Kingdom
Substances： See more » Antibodies, Antineutrophil CytoplasmicAntibodies, Monoclonal, Murine-DerivedImmunologic FactorsImmunosuppressive AgentsRituximabCyclophosphamidePrednisoloneAzathioprine
Year: 2013 PMID： 23490639 DOI： 10.1016/j.lpm.2013.01.049
Source DB: PubMed Journal: Presse Med ISSN： 0755-4982 Impact factor: 1.228